Trials / Recruiting
RecruitingNCT03821467
Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects
Short- and Long-term Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography Measurements in Healthy Subjects - a Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Dual beam Doppler Fourier-domain Optical coherence tomography (DOCT) is a noninvasive technique to quantify total retinal blood flow. To enable further development of this technique it is essential to assess short- and long-term reproducibility of DOCT blood flow measurements.
Detailed description
In the present study, total retinal blood flow will be measured with DOCT at multiple time points to gain information of short- and long-term reproducibility. In addition, provocation with flickering light will be performed, which is known to lead to vasodilatation and an increase in retinal blood flow in healthy subjects. Vessel diameters will also be measured using the Dynamic Vessel Analyzer (DVA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dual beam Doppler Fourier-domain OCT (DOCT) | Retinal blood flow will be assessed using DOCT. |
| DEVICE | Dynamic Vessel Analyzer (DVA) | Retinal vessel diameters and oxygen saturation will be measured with the DVA device. |
| DEVICE | Optical coherence tomography (OCT) | Retinal morphology will be imaged using OCT. |
Timeline
- Start date
- 2018-11-19
- Primary completion
- 2025-12-12
- Completion
- 2025-12-12
- First posted
- 2019-01-29
- Last updated
- 2025-05-16
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03821467. Inclusion in this directory is not an endorsement.